You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Newly released APIs are the first products from the Global Alliance for Genomics and Health's strategic roadmap for interoperability of genomic information.
The new genomes allowed the researchers to add 62 new coding loci to the mouse reference genome annotation and to identify a large new gene.
Multi-Omics Factor Analysis looks for underlying causes of tumor variations by parsing and weighting genomic, epigenomic, transcriptomic, proteomic, and metabolomic data.
At the Guardian, EBI's Ewan Birney writes that DNA is a tool people can use, not a harbinger of the future.
Called GA4GH Connect, it calls on the alliance's 500-plus members to develop new data sharing standards for use in major international genomic data initiatives.
The team aims to release the new resource sometime next year, with the hope that it will become as widely used as other institute databases.
Areas of concern are the recruitment of talented scientists, as well as retaining access to EU funding, European research collaborations, and clinical trials.
The release has been accompanied by acute interest from the genomics community, which views the resource as a "game changer" for anyone working in human genetics.
The International Mouse Phenotyping Consortium has systematically studied knockout mice to find new disease models and candidate disease genes.
The computational method, called DeepCpG, is designed to tease out missing epigenetic marks and related DNA motifs in single-cell DNA methylation data.
Master's and doctoral students in the UK call on funding groups to extend their grants for the duration of the disruption caused by the COVID-19 outbreak, the Guardian reports.
Squid can make edits to their RNA within the cytoplasm of their axons, Science News reports.
The Chan Zuckerberg Initiative is putting $25 million toward COVID-19 treatment research, according to the Verge.
In Science this week: researchers engineer version of Cas9 that is nearly PAM-less, and more.